Day 1 |
Registration and welcome
|
|
Day 1 |
Diabetic Foot
|
Professor Frances Game, University Hospitals of Derby & Burton NHS Foundation Trust |
Day 1 |
Why diabetologists should screen for Testosterone Deficiency in men with T2DM and improve clinical outcomes and mortality
|
Professor Thomas Hugh Jones, Barnsley Hospital NHS Foundation Trust |
Day 1 |
Reducing cardiovascular risk in type 2 diabetes
|
Dr. Bob Ryder, City Hospital, Birmingham |
Day 1 |
Reducing cardiovascular risk even further - Icosapent Ethyl
|
Mr. Philip Newland-Jones, Faculty of Medicine, University of Southampton |
Day 1 |
Refreshments and exhibition
|
|
Day 1 |
New horizons for treating obesity
|
Professor Barbara McGowan, Guys and St Thomas's Hospital |
Day 1 |
The return of DJBL (formerly known as EndoBarrier)
|
Dr. Bob Ryder, City Hospital, Birmingham |
Day 1 |
Diabetes and Frailty
|
Dr. Amar Puttanna |
Day 1 |
Lunch and exhibition
|
|
Day 1 |
Obesity and T2DM in young people
|
Associate Professor Pooja Sachdev, Queen's Medical Centre, Nottingham |
Day 1 |
Screening, follow up and prevention
|
Dr. Rachel Besser, Centre for Human Genetics, University of Oxford |
Day 1 |
HCL cases
|
Associate Professor Emma Wilmot, University of Nottingham and University Hospitals of Derby & Burton NHS Trust Dr. Thomas Crabtree, University Hospitals of Derby and Burton NHS Trust |
Day 1 |
Islet Cell Transplantation
|
Dr. Alistair Lumb, Oxford University Hospitals NHS Foundation Trust |
Day 1 |
Afternoon refreshments and exhibition
|
|
Day 1 |
Managing hyperglycaemic emergencies in 2025
|
Dr. Punith Kempegowda, University of Birmingham |
Day 1 |
Debate - Obesity drugs are unaffordable for the NHS
|
Professor Iskandar Idris, University of Nottingham Professor Vinod Patel, Warwick Medical School |
Day 1 |
Closing
|
To Be Confirmed |
